Clémence Basse

712 total citations
27 papers, 252 citations indexed

About

Clémence Basse is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Clémence Basse has authored 27 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Neurology. Recurrent topics in Clémence Basse's work include Lung Cancer Treatments and Mutations (12 papers), Myasthenia Gravis and Thymoma (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Clémence Basse is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Myasthenia Gravis and Thymoma (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Clémence Basse collaborates with scholars based in France, United States and Spain. Clémence Basse's co-authors include Michel Arock, Nicolas Girard, Paul Cottu, Alexa B. Schrock, Laurence Bozec, Shakti Ramkissoon, Jeffrey S. Ross, Xavier Paolettí, Youlia Kirova and Keith Killian and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Molecular Sciences.

In The Last Decade

Clémence Basse

25 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clémence Basse France 7 147 61 59 48 39 27 252
Marco Maria Aiello Italy 12 224 1.5× 88 1.4× 79 1.3× 32 0.7× 54 1.4× 26 407
Kristen Labbe United States 6 146 1.0× 63 1.0× 51 0.9× 12 0.3× 65 1.7× 6 233
Bintao Hu China 11 94 0.6× 94 1.5× 75 1.3× 12 0.3× 39 1.0× 22 317
Tangpeng Xu China 10 94 0.6× 74 1.2× 66 1.1× 26 0.5× 39 1.0× 18 262
Ana López‐Alfonso Spain 6 170 1.2× 126 2.1× 74 1.3× 10 0.2× 89 2.3× 14 340
Nandini Menon India 9 107 0.7× 36 0.6× 102 1.7× 6 0.1× 9 0.2× 46 238
Hongyun Gong China 9 99 0.7× 85 1.4× 49 0.8× 35 0.7× 72 1.8× 25 265
Simone Navarra Italy 8 140 1.0× 133 2.2× 32 0.5× 18 0.4× 31 0.8× 13 266
Bin Quan China 7 49 0.3× 20 0.3× 17 0.3× 26 0.5× 73 1.9× 16 186
Tariq U. Azam United States 5 114 0.8× 45 0.7× 30 0.5× 14 0.3× 27 0.7× 15 240

Countries citing papers authored by Clémence Basse

Since Specialization
Citations

This map shows the geographic impact of Clémence Basse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clémence Basse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clémence Basse more than expected).

Fields of papers citing papers by Clémence Basse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clémence Basse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clémence Basse. The network helps show where Clémence Basse may publish in the future.

Co-authorship network of co-authors of Clémence Basse

This figure shows the co-authorship network connecting the top 25 collaborators of Clémence Basse. A scholar is included among the top collaborators of Clémence Basse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clémence Basse. Clémence Basse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basse, Clémence, Lara Chalabreysse, Pieter Bonte, et al.. (2025). Stage shift from Masaoka-Koga to ninth TNM system in thymic epithelial tumors. 4. 100027–100027.
2.
Huet, C., Clémence Basse, Pieter Bonte, et al.. (2024). Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy. Clinical Lung Cancer. 25(8). e402–e410.e3. 1 indexed citations
4.
Basse, Clémence, Matthieu Carton, Maud Milder, et al.. (2024). Real-World Survival Impact of New Treatment Strategies for Lung Cancer: A 2000–2020 French Cohort. Cancers. 16(15). 2768–2768. 4 indexed citations
5.
Basse, Clémence, Julien Masliah‐Planchon, Céline Callens, et al.. (2023). Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 24(4). 3802–3802. 1 indexed citations
6.
Mawet, Marie, Clémence Basse, Joseph Gligorov, et al.. (2023). Second-trimester medical abortion after exposure to lorlatinib during early pregnancy, a case report. Journal of Gynecology Obstetrics and Human Reproduction. 52(10). 102673–102673. 1 indexed citations
7.
Basse, Clémence, et al.. (2022). Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case Report. Frontiers in Oncology. 11. 814544–814544. 4 indexed citations
9.
Mascaux, Céline, M. Zysman, Aurélie Swalduz, et al.. (2022). 37P Sotorasib-induced liver and non-liver toxicity associated with sequential sotorasib following anti-PD(L)1 in KRASG12C mutant lung cancer. Annals of Oncology. 33. S49–S50. 5 indexed citations
10.
Girard, Nicolas, Clémence Basse, Alexa B. Schrock, et al.. (2022). Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers. The Oncologist. 27(11). 919–929. 27 indexed citations
11.
Benítez, José Carlos, Éric Dansin, Giuseppe Giaccone, et al.. (2022). Lenvatinib for the treatment of thymic epithelial tumors (TETs): A real-life multicenter experience.. Journal of Clinical Oncology. 40(16_suppl). 8585–8585. 1 indexed citations
12.
Basse, Clémence, et al.. (2022). Brief Report on Teleconsultation in Lung Cancer: Toward a Semiotic Paradigm Shift?. JTO Clinical and Research Reports. 3(6). 100333–100333. 2 indexed citations
13.
Basse, Clémence & Nicolas Girard. (2021). Thymic tumours and their special features. European Respiratory Review. 30(162). 200394–200394. 5 indexed citations
14.
Basse, Clémence, et al.. (2021). Carcinome bronchique non à petites cellules : nouvelles addictions oncogéniques, diagnostic et perspectives. Revue des Maladies Respiratoires. 38(5). 477–488. 2 indexed citations
15.
Basse, Clémence, Angela Botticella, Thierry Jo Molina, et al.. (2021). RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection. Clinical Lung Cancer. 22(5). 469–472. 10 indexed citations
16.
17.
Basse, Clémence, et al.. (2021). Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center. Lung Cancer. 157. 79–84. 6 indexed citations
18.
Basse, Clémence, Aurélie Swalduz, Matteo Giaj Levra, et al.. (2020). Immunothérapie des cancers bronchiques non à petites cellules métastatiques, de la première ligne à la résistance et sa prise en charge. Bulletin du Cancer. 107(7-8). 779–791. 1 indexed citations
19.
Vuagnat, Perrine, Maxime Frélaut, Toulsie Ramtohul, et al.. (2020). COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Research. 22(1). 55–55. 80 indexed citations
20.
Sablin, Marie‐Paule, Francesco Ricci, Delphine Loirat, et al.. (2017). Les inhibiteurs du cycle cellulaire et cancer du sein hormonodépendant. Bulletin du Cancer. 104(2). 114–122. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026